iScience· Murata·收录于· 19 小时前
Efficacy of second-line therapies for SMARCA4-mutated NSCLC based on a nationwide comprehensive genomic profiling database
Efficacy of second-line therapies for SMARCA4-mutated NSCLC based on a nationwide comprehensive genomic profiling database
来源:iScience · doi.org